[VIR] YoY Quarter Result on 30-Sep-2023 [#Q3]

Stock
[VIR] Vir Biotechnology, Inc.
Announcement Date
03-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- 16.10%
YoY- -193.21%
Quarter Report
VIR's Result
VIR's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 2,380 -4,098 371,432 102,713 188 237 114 65.86%
PBT -213,540 -166,626 217,732 110,762 -84,587 -48,327 -33,456 36.15%
Tax 177 -3,213 42,420 334 22 -13 -712 -
NP -213,717 -163,413 175,312 110,428 -84,609 -48,314 -33,456 36.17%
Tax Rate - - -19.48% -0.30% - - - -
Total Cost 216,097 159,315 196,120 -7,715 84,797 48,551 33,570 36.35%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin -8,979.71 3,987.63 47.20 107.51 -45,004.79 -20,385.65 -29,347.37 -17.89%
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
EPS -1.56 -1.22 1.32 0.85 -0.67 -0.44 -0.35 28.25%
EPS Diluted -1.56 -1.22 1.30 0.82 -0.67 -0.44 -0.35 28.25%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.